09/08/2025 4:45 PM | GT Biopharma (Issuer) Kramer Hilary (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/08/2025 4:45 PM | CASAMENTO CHARLES J (Reporting) GT Biopharma (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/08/2025 4:45 PM | GT Biopharma (Issuer) URBAN ALAN LOUIS (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/08/2025 4:45 PM | Breen Michael Martin (Reporting) GT Biopharma (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/08/2025 4:45 PM | GT Biopharma (Issuer) Mun-Gavin David C. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/29/2025 3:15 PM | GT Biopharma (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
07/24/2025 3:34 PM | GT Biopharma (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
07/03/2025 7:30 AM | GT Biopharma (Filer)
| Form 424B3 | |
07/02/2025 11:15 PM | GT Biopharma (Filer)
| Form EFFECT | |
06/27/2025 4:30 PM | GT Biopharma (Filer)
| Form S-1/A | |
06/11/2025 4:30 PM | GT Biopharma (Filer)
| Form S-1 Registration statement under Securities Act of 1933 | |
Get the Latest News and Ratings for GTBP and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for GT Biopharma and its competitors with MarketBeat's FREE daily newsletter.
|
06/11/2025 3:30 PM | GT Biopharma (Filer)
| Form DEF 14A | |
06/11/2025 3:31 PM | GT Biopharma (Filer)
| Form DEFA14A | |
06/02/2025 6:46 PM | BRISTOL INVESTMENT FUND LTD (Filed by) GT Biopharma (Subject)
| Form SCHEDULE 13G/A | |
05/29/2025 3:15 PM | GT Biopharma (Issuer) Ritter Andrew J (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
05/27/2025 3:15 PM | GT Biopharma (Filer)
| Form D Notice of Exempt Offering of Securities | |
05/27/2025 3:15 PM | GT Biopharma (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/14/2025 8:22 AM | Five Narrow Lane LP (Filed by) GT Biopharma (Subject)
| Form SCHEDULE 13G | |
05/13/2025 8:01 AM | GT Biopharma (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
04/14/2025 3:05 PM | GT Biopharma (Filer)
| Form 10-K/A | |
03/14/2025 8:00 AM | GT Biopharma (Filer)
| Form 424B3 | |
03/13/2025 11:15 PM | GT Biopharma (Filer)
| Form EFFECT | |
03/07/2025 4:29 PM | GT Biopharma (Filer)
| Form D Notice of Exempt Offering of Securities | |
03/06/2025 4:20 PM | GT Biopharma (Filer)
| Form S-3 Registration statement under Securities Act of 1933 | |
02/26/2025 4:07 PM | GT Biopharma (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/24/2025 7:00 AM | GT Biopharma (Filer)
| Form RW | |
02/21/2025 4:01 PM | GT Biopharma (Filer)
| Form 10-K Annual report pursuant to Section 13 or 15(d) | |
02/07/2025 8:32 AM | GT Biopharma (Filer)
| Form S-1/A | |
01/27/2025 7:31 AM | GT Biopharma (Filer)
| Form S-1/A | |
01/27/2025 6:00 AM | GT Biopharma (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
12/23/2024 4:23 PM | GT Biopharma (Filer)
| Form S-1 Registration statement under Securities Act of 1933 | |
11/27/2024 3:05 PM | GT Biopharma (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/21/2024 8:25 AM | GT Biopharma (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/21/2024 8:13 PM | GT Biopharma (Issuer) URBAN ALAN LOUIS (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/17/2024 10:15 AM | CYTOVANCE BIOLOGICS INC (Filed by) GT Biopharma (Subject)
| Form SCHEDULE 13G/A | |